Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches

Following Alzheimer’s, Parkinson’s disease (PD) is the second-most common neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile, and massive social costs worldwide. Despite this, no disease-modifying therapy is available. PD is tightly associated with α-synuclein (...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidović, Marija, Rikalovic, Milena G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179656/
https://www.ncbi.nlm.nih.gov/pubmed/35681426
http://dx.doi.org/10.3390/cells11111732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179656/
https://www.ncbi.nlm.nih.gov/pubmed/35681426
http://dx.doi.org/10.3390/cells11111732

Ejemplares similares